CRISPR gene-editing therapy has made a breakthrough in malaria prevention by modifying a single gene in mosquitoes, rendering them incapable of transmitting the disease. Researchers from UC San Diego, Johns Hopkins, and UC Berkeley discovered that altering an amino acid in mosquitoes can block malaria parasites from reaching salivary glands, allowing for the potential release of these genetically modified mosquitoes to combat the 600,000 annual malaria deaths.
Want More Context? 🔎